MiR-32-5p Regulates the Proliferation and Metastasis of Cervical Cancer Cells by Targeting HOXB8
Overview
Pharmacology
Toxicology
Affiliations
Objective: To investigate the effects of miR-32-5p on the biological behaviors of cervical cancer (CCa), the relevant mechanism was studied in CCa cell lines (HeLa) in vitro.
Patients And Methods: The expression level of miR-32-5p was detected by quantitative reverse transcription polymerase chain reaction (qRT-PCR). TargetScan, miRDB, microRNA databases and Luciferase method were conducted to predict and validate the target gene of miR-32-5p; the effects of miR-32-5p on cell proliferation, clone formation, invasion and migration capacity were analyzed in vitro study.
Results: We found miR-32-5p to be significantly inhibited in CCa tissues and cells. Bioinformatics approach together with Luciferase method screened Homeobox B8 (HOXB8) as a downstream regulatory target of miR-32-5p. Besides, HOXB8 was incredibly high expression in CCa tissues and cells. After transfection in HeLa cells by miR-32-5p mimics, HOXB8 expression was indicated to be negatively correlated with miR-32-5p both in qRT-PCR and Western blot (WB) assays. The subsequent experiments showed that decreased expression of HOXB8 resulting from up-regulation of miR-32-5p could weaken the cell proliferation, clone formation, invasion and migration ability of HeLa cells.
Conclusions: MiR-32-5p could inhibit the cellular malignant behavior through regulating the expression of HOXB8 in HeLa cells. We provide a new clue for the study of molecular mechanisms of CCa. MiR-32-5p/HOXB8 axis might serve as potential target for the clinical diagnosis and treatment of CCa.
MicroRNAs, long non-coding RNAs, and circular RNAs and gynecological cancers: focus on metastasis.
Rezaee A, Ahmadpour S, Jafari A, Aghili S, Tamehri Zadeh S, Rajabi A Front Oncol. 2023; 13:1215194.
PMID: 37854681 PMC: 10580988. DOI: 10.3389/fonc.2023.1215194.
Overexpression of miR-32 in Chinese hamster ovary cells increases production of Fc-fusion protein.
Bazaz M, Adeli A, Azizi M, Karimipoor M, Mahboudi F, Davoudi N AMB Express. 2023; 13(1):45.
PMID: 37160545 PMC: 10170017. DOI: 10.1186/s13568-023-01540-z.
Huang P, Wang L, Wang Y, Tsai M, Lin T, Liao C Cells. 2023; 12(6).
PMID: 36980210 PMC: 10047572. DOI: 10.3390/cells12060869.
Endometrial Carcinoma: Molecular Cytogenetics and Transcriptomic Profile.
Brunetti M, Panagopoulos I, Vitelli V, Andersen K, Hveem T, Davidson B Cancers (Basel). 2022; 14(14).
PMID: 35884597 PMC: 9325179. DOI: 10.3390/cancers14143536.
Cheng S, Wang W J Bone Miner Metab. 2022; 40(4):554-560.
PMID: 35639175 DOI: 10.1007/s00774-022-01319-5.